ATE206930T1 - Verwendung von osteoblast-proliferationsfaktor - Google Patents

Verwendung von osteoblast-proliferationsfaktor

Info

Publication number
ATE206930T1
ATE206930T1 AT95111224T AT95111224T ATE206930T1 AT E206930 T1 ATE206930 T1 AT E206930T1 AT 95111224 T AT95111224 T AT 95111224T AT 95111224 T AT95111224 T AT 95111224T AT E206930 T1 ATE206930 T1 AT E206930T1
Authority
AT
Austria
Prior art keywords
proliferation factor
osteoblast proliferation
bone
diseaese
prevention
Prior art date
Application number
AT95111224T
Other languages
English (en)
Inventor
Akira Kudo
Tohru Nakanishi
Masaharu Takigawa
Original Assignee
Aventis Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Ltd filed Critical Aventis Pharma Ltd
Application granted granted Critical
Publication of ATE206930T1 publication Critical patent/ATE206930T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/185Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT95111224T 1994-07-22 1995-07-18 Verwendung von osteoblast-proliferationsfaktor ATE206930T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20125794A JP3738281B2 (ja) 1994-07-22 1994-07-22 新規な骨芽細胞増殖因子

Publications (1)

Publication Number Publication Date
ATE206930T1 true ATE206930T1 (de) 2001-11-15

Family

ID=16437950

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95111224T ATE206930T1 (de) 1994-07-22 1995-07-18 Verwendung von osteoblast-proliferationsfaktor

Country Status (14)

Country Link
US (1) US6080720A (de)
EP (1) EP0704219B1 (de)
JP (1) JP3738281B2 (de)
KR (1) KR100361717B1 (de)
AT (1) ATE206930T1 (de)
AU (1) AU693567B2 (de)
CA (1) CA2154403A1 (de)
DE (1) DE69523250T2 (de)
DK (1) DK0704219T3 (de)
ES (1) ES2161809T3 (de)
FI (1) FI953514A (de)
HU (1) HU217082B (de)
NO (1) NO952912L (de)
PT (1) PT704219E (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8936804B2 (en) * 2010-01-15 2015-01-20 Rutgers, The State University Of New Jersey Use of vanadium compounds to accelerate bone healing
EP2648718B1 (de) 2010-12-10 2019-05-08 Rutgers, the State University of New Jersey Implantierbare vorrichtungen mit insulin-mimetikum-verbundstoffbeschichtung und verfahren dafür
WO2013006798A1 (en) 2011-07-06 2013-01-10 University Of Medicine And Dentistry Of New Jersey Vandium compounds as therapeutic adjuncts for cartilage regeneration and repair
US20140322292A1 (en) 2010-12-10 2014-10-30 Rutgers, The State University Of New Jersey Insulin-mimetics as therapeutic adjuncts for bone regeneration

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL95511A (en) * 1989-08-30 2000-10-31 Max Planck Gesellschaft Neurotrophin-3 a novel neurotrophic factor related to nerve growth and brain derived neurotrophic factor
AU2460595A (en) * 1994-05-06 1995-11-29 Regeneron Pharmaceuticals, Inc. Methods based on the role of neurotrophin 3 in female reproduction

Also Published As

Publication number Publication date
HU9502202D0 (en) 1995-09-28
US6080720A (en) 2000-06-27
DE69523250D1 (de) 2001-11-22
DE69523250T2 (de) 2002-07-04
EP0704219A2 (de) 1996-04-03
JP3738281B2 (ja) 2006-01-25
JPH0834744A (ja) 1996-02-06
EP0704219B1 (de) 2001-10-17
CA2154403A1 (en) 1996-01-23
HU217082B (hu) 1999-11-29
EP0704219A3 (de) 1997-12-10
KR100361717B1 (ko) 2003-07-07
DK0704219T3 (da) 2002-02-04
FI953514A (fi) 1996-01-23
AU2710595A (en) 1996-02-01
NO952912D0 (no) 1995-07-21
ES2161809T3 (es) 2001-12-16
FI953514A0 (fi) 1995-07-20
KR960003741A (ko) 1996-02-23
PT704219E (pt) 2002-03-28
NO952912L (no) 1996-01-23
HUT73185A (en) 1996-06-28
AU693567B2 (en) 1998-07-02

Similar Documents

Publication Publication Date Title
UA29505C2 (uk) Фармацевтична композиція для лікування і/або профілактики розрідження кістки і спосіб лікування і/або профілактики розрідження кістки у ссавців
RU94027680A (ru) Паращитовидный гормон и ралоксифон для увеличения массы кости, фармацевтический состав и способ увеличения костной массы
DE69332732T2 (de) Pharmazeutische Zusammensetzung und Methode zur Behandlung von Hyperlipidämie und Arterioskerose
DE69825292D1 (de) Verwendung von inosine zur herstellung eines medikamentes zur stimulierung des axonwachstums von zns-neuronen
MXPA02006679A (es) Composicion farmaceutica.
DE69431046D1 (de) Rekombinante adenoviren und deren verwendung in der gentherapie zur behandlung von augenerkrankungen
GR3023596T3 (en) Neural implant system
DE69420229D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
DE69420776T2 (de) Idebenone-haltige Zusammensetzungen zur Behandlung von M. Alzheimer
ATE206930T1 (de) Verwendung von osteoblast-proliferationsfaktor
DE69314586T2 (de) Arzneimittelzusammensetzung enthaltend TCF-II
DE69424747D1 (de) Pharmazeutische Zusammensetzung zur Vorbeugung oder Behandlung von Knochenbrüchen
NO20010984D0 (no) Anvendelse av R(+)-<alfa>-(2,3-dimetoksyfenyl)-1-[2-(4- fluorfenyl)etyl]-4-piperidinmetanol for behandling av søvnforstyrrelser
AU639693B2 (en) Laser apparatus for treating bone and tooth tissue
TW224943B (en) The pharmaceutical composition for the stimulation of bone formation
IL103499A0 (en) Pharmaceutical compositions for treating anxiety in benzodiazepine withdrawn patients
UA10221A (uk) Спосіб лікування рецидивного бронхіту у дітей
SG64899A1 (en) Method and composition for treatment of patients having decompsated liver disease

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee